Clinical trial
CBT as an Adjunct to SRIs in the Treatment of BDD
NCT00211809 · Icahn School of Medicine at Mount Sinai, Other · Terminated
Key facts
| NCT number | NCT00211809 |
|---|---|
| Title | CBT as an Adjunct to SRIs in the Treatment of BDD |
| Official title | A Controlled Trial of Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in Body Dysmorphic Disorder |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Body Dysmorphic Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Cognitive Behavioral Therapy, Venlafaxine |
| Enrollment | 17 |
| Start date | Sep 1, 2008 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: